UK markets closed

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
113.300+0.200 (+0.18%)
At close: 4:08PM HKT
Currency in HKD

Valuation measures

Market cap (intra-day) 5486.96B
Enterprise value 3475.67B
Trailing P/E 148.64
Forward P/E 1100.00
PEG ratio (5-yr expected) 11.96
Price/sales (ttm)51.13
Price/book (mrq)12.14
Enterprise value/revenue 358.91
Enterprise value/EBITDA 7141.57

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 355.49%
S&P500 52-week change 333.64%
52-week high 3148.000
52-week low 370.133
50-day moving average 3117.709
200-day moving average 3119.148

Share statistics

Avg vol (3-month) 317.65M
Avg vol (10-day) 310.92M
Shares outstanding 54.24B
Implied shares outstanding 6N/A
Float 83.58B
% held by insiders 115.65%
% held by institutions 146.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 316 Nov 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021


Profit margin 34.61%
Operating margin (ttm)34.53%

Management effectiveness

Return on assets (ttm)5.42%
Return on equity (ttm)12.01%

Income statement

Revenue (ttm)8.08B
Revenue per share (ttm)1.97
Quarterly revenue growth (yoy)126.70%
Gross profit (ttm)2.53B
Net income avi to common (ttm)2.79B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)150.30%

Balance sheet

Total cash (mrq)13.94B
Total cash per share (mrq)3.29
Total debt (mrq)4.6B
Total debt/equity (mrq)13.69
Current ratio (mrq)4.04
Book value per share (mrq)7.84

Cash flow statement

Operating cash flow (ttm)2.25B
Levered free cash flow (ttm)-6.86B